| dc.creator | Brotis A.G., Gatos C., Fountas K.N. | en |
| dc.date.accessioned | 2023-01-31T07:40:35Z | |
| dc.date.available | 2023-01-31T07:40:35Z | |
| dc.date.issued | 2018 | |
| dc.identifier | 10.1007/s00701-018-3661-2 | |
| dc.identifier.issn | 00016268 | |
| dc.identifier.uri | http://hdl.handle.net/11615/72114 | |
| dc.description.abstract | [No abstract available] | en |
| dc.language.iso | en | en |
| dc.source | Acta Neurochirurgica | en |
| dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85053192930&doi=10.1007%2fs00701-018-3661-2&partnerID=40&md5=734e4eaad53601d157d7f7e2c5329fd5 | |
| dc.subject | dexamethasone | en |
| dc.subject | dexamethasone | en |
| dc.subject | adjuvant therapy | en |
| dc.subject | clinical evaluation | en |
| dc.subject | comparative study | en |
| dc.subject | drug efficacy | en |
| dc.subject | human | en |
| dc.subject | infection risk | en |
| dc.subject | Letter | en |
| dc.subject | meta analysis (topic) | en |
| dc.subject | metabolic disorder | en |
| dc.subject | monotherapy | en |
| dc.subject | neurosurgery | en |
| dc.subject | priority journal | en |
| dc.subject | qualitative analysis | en |
| dc.subject | quantitative analysis | en |
| dc.subject | recurrence risk | en |
| dc.subject | subdural hematoma | en |
| dc.subject | systematic review (topic) | en |
| dc.subject | treatment outcome | en |
| dc.subject | subdural hematoma | en |
| dc.subject | Dexamethasone | en |
| dc.subject | Hematoma, Subdural, Chronic | en |
| dc.subject | Humans | en |
| dc.subject | Springer-Verlag Wien | en |
| dc.title | Letter to the editor regarding “Dexamethasone for chronic subdural haematoma: a systematic review and meta-analysis” | en |
| dc.type | other | en |